Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,09 USD | +3,46% |
|
+5,26% | -47,95% |
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Sean Carrick
CEO | Chief Executive Officer | 56 | 15-07-14 |
Lowell Holden
DFI | Director of Finance/CFO | 82 | 15-07-14 |
Douglas Karas
BRD | Director/Board Member | 59 | 04-04-16 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Lowell Holden
DFI | Director of Finance/CFO | 82 | 15-07-14 |
Sean Carrick
CEO | Chief Executive Officer | 56 | 15-07-14 |
Douglas Karas
BRD | Director/Board Member | 59 | 04-04-16 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 169 729 565 | 101 841 640 ( 60,00 %) | 0 | 60,00 % |
Bedrijfsgegevens
Nascent Biotech, Inc.
623 US Highway 1 Suite 407
33408, North Palm Beach
+
http://www.nascentbiotech.com![Adres Nascent Biotech, Inc.(NBIO)](https://cdn.zonebourse.com/static/address/120792813.png)
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
-47,95% | 15,35 mln. | |
+14,84% | 121 mld. | |
+18,31% | 112 mld. | |
+2,94% | 22,72 mld. | |
-18,26% | 20,82 mld. | |
-18,47% | 16,66 mld. | |
-42,36% | 16,36 mld. | |
-14,23% | 16,19 mld. | |
-0,68% | 13,17 mld. | |
+21,87% | 11,11 mld. |
- Beurs
- Aandelen
- Koers NBIO
- Onderneming Nascent Biotech, Inc.